June 30, 2017

Under the agreement, Sandoz will develop and commercialize a generic of a major inhaled combination therapy delivered using a pressurized metered dose inhaler that Vectura Group is developing. 

June 29, 2017

The company said that the creams had combined U.S. sales of $38 million for the 12 months ended Aril 2017, according to QuintilesIMS data.

June 29, 2017

The drug had combined sales of $188 million for the 12 months ended April 2017, the company said.

June 28, 2017

Patients with diabetes who create an account on the Blink Health website or mobile app will be able to receive a year’s supply of metformin, glipizide and pioglitazone for free. 

June 28, 2017

The Food and Drug Administration has shared a list of drugs without patents or exclusivity that don't yet have generics, and has outlined a new plan for expediting review of generics of drugs with limited competition.

June 27, 2017

The drug is indicated to treat schizophrenia and to control severe nausea and vomiting in adults.

June 26, 2017

Born in Rajgarh, Rajasthan, Gupta moved to Mumbai and founded Lupin in 1968 with the goal of providing high-quality medicines at affordable prices.

June 22, 2017

Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3x10 blister cards.

June 22, 2017

The Food and Drug Administration’s Drug Competition Action Plan begins with a public hearing on July 18 to assess the places where FDA regulations could be creating obstacles to generic access.

June 22, 2017

According to the CDC, American adults are behind on routine annual vaccinations.

June 22, 2017

Teva’s generic will be available in 75- and 150-mg dosage strengths.

June 20, 2017

The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.

June 20, 2017

This launch marks the seventh product ANI has re-commercialized after acquiring a portfolio of discontinued generic abbreviated new drug applications. 

June 20, 2017

The company said that this marks its fourth first-to-market generic launch since June 2016.

June 20, 2017

The drug had U.S. sales of $15 million for the 12 months ended April 2017, Perrigo said.

June 20, 2017

The drug is indicated as an adjunctive therapy to relieve discomfort associated with acute, painful musculoskeletal conditions.

June 19, 2017
The drug is indicated for the control of serum phosphorus in patients with chronic kidney disease.
 
June 16, 2017
The company is distributing the generic in 30-, 90- and 500-count bottle sizes, and has begun shipping the product from its Kentucky distribution center.
 
June 15, 2017

CVS Health’s April survey found that 88% of respondents are somewhat or very concerned about the high cost of prescription drugs.

June 13, 2017
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). 
June 13, 2017
The drug had U.S. sales of approximately $2.7 billion for the 12 months ended in March, according to QuintilesIMS data.
June 13, 2017

The award recognizes character and professional accomplishments, as well as leadership in HDA, the industry and the community.

June 12, 2017

The latest report on generics cost savings, compiled by the QuintilesIMS Institute on behalf of the Association for Accessible Medicines, highlights the key role generics play in healthcare cost savings. 

June 12, 2017

The drug saw U.S. sales of $293 million for the 12 months ended April 2017, according to QuintilesIMS data.